Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaolin Ge

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
Annals of Palliative Medicine|December 24, 2019
A retrospective study of postoperative radiotherapy for locally advanced esophageal squamous cell carcinomaZhaoyue Zhang, Liping Xu, Xiaoke Di, et al.
The Oncologist|January 6, 2026
Induction chemoimmunotherapy followed by concurrent radiotherapy in patients with locally advanced esophageal cancer: a single-arm phase 2 trialHui Chen, Zeyuan Liu, Wang Zheng, et al.
Medicine|September 17, 2025
Combining standard clinical blood values for improving survival prediction in patients with unresectable esophageal carcinoma: A retrospective studyLei Zhao, Dan Mei, Xiaolin Ge, et al.
Panminerva Medica|July 30, 2019
MAGEA3 serves as an independent indicator for predicting the prognosis of ESCCShenxiang Liu, Hongyan Chen, Xiaolin Ge, et al.
Oncology Letters|August 28, 2019
Gross tumor volume is an independent prognostic factor in patients with postoperative locoregional recurrence of esophageal squamous cell carcinomaYu Shi, Xiaolin Ge, Zhenzhen Gao, et al.
Angewandte Chemie (International Ed. in English)|January 22, 2026
Molecular-Level Energy Dissipation and Micropore Engineering Synergistically Enhance Anion Exchange Membrane PerformanceCui Yang, Yu Huang, Wanjie Song, et al.
BMC Cancer|October 1, 2025
Efficacy of local radiotherapy in first-line treatment of recurrent or metastatic esophageal squamous cell carcinoma based on immunotherapyDandan Yu, Fei Li, Liping Xu, et al.
Cancer Management and Research|November 12, 2021
Circulating Tumor Cells in Esophageal Squamous Cell Carcinoma - Mini ReviewYujing Shi, Xiaolin Ge, Mengyang Ju, et al.
International Journal of Cancer|May 14, 2026
Nimotuzumab Combined With Concurrent Curative Radiotherapy and S-1 in 75 Years and Older Patients With Stage II-IVB Esophageal Squamous Cell Carcinoma: A Phase II StudyXiaojie Xia, Jingze Yan, Lu Xu, et al.
Current Oncology (Toronto, Ont.)|April 25, 2025
Real-World Clinical Outcomes of Trilaciclib for the Prevention of Myelosuppression in Patients with Esophageal Cancer Undergoing ChemotherapyHui Chen, Jingze Yan, Zeyuan Liu, et al.
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Annals of Palliative Medicine|December 24, 2019
A retrospective study of postoperative radiotherapy for locally advanced esophageal squamous cell carcinomaZhaoyue Zhang, Liping Xu, Xiaoke Di, et al.
The Oncologist|January 6, 2026
Induction chemoimmunotherapy followed by concurrent radiotherapy in patients with locally advanced esophageal cancer: a single-arm phase 2 trialHui Chen, Zeyuan Liu, Wang Zheng, et al.
Medicine|September 17, 2025
Combining standard clinical blood values for improving survival prediction in patients with unresectable esophageal carcinoma: A retrospective studyLei Zhao, Dan Mei, Xiaolin Ge, et al.
Panminerva Medica|July 30, 2019
MAGEA3 serves as an independent indicator for predicting the prognosis of ESCCShenxiang Liu, Hongyan Chen, Xiaolin Ge, et al.
Oncology Letters|August 28, 2019
Gross tumor volume is an independent prognostic factor in patients with postoperative locoregional recurrence of esophageal squamous cell carcinomaYu Shi, Xiaolin Ge, Zhenzhen Gao, et al.
Angewandte Chemie (International Ed. in English)|January 22, 2026
Molecular-Level Energy Dissipation and Micropore Engineering Synergistically Enhance Anion Exchange Membrane PerformanceCui Yang, Yu Huang, Wanjie Song, et al.
BMC Cancer|October 1, 2025
Efficacy of local radiotherapy in first-line treatment of recurrent or metastatic esophageal squamous cell carcinoma based on immunotherapyDandan Yu, Fei Li, Liping Xu, et al.
Cancer Management and Research|November 12, 2021
Circulating Tumor Cells in Esophageal Squamous Cell Carcinoma - Mini ReviewYujing Shi, Xiaolin Ge, Mengyang Ju, et al.
International Journal of Cancer|May 14, 2026
Nimotuzumab Combined With Concurrent Curative Radiotherapy and S-1 in 75 Years and Older Patients With Stage II-IVB Esophageal Squamous Cell Carcinoma: A Phase II StudyXiaojie Xia, Jingze Yan, Lu Xu, et al.
Current Oncology (Toronto, Ont.)|April 25, 2025
Real-World Clinical Outcomes of Trilaciclib for the Prevention of Myelosuppression in Patients with Esophageal Cancer Undergoing ChemotherapyHui Chen, Jingze Yan, Zeyuan Liu, et al.
Pageof 10